Picture supply: Getty Photographs
I keep in mind the times when traders received in an actual sweat over premium fizzy drinks maker Fevertree Drinks (LSE: FEVR).
The AIM-listed firm captured the zeitgeist, because the nation went gin loopy and Fevertree provided the upmarket tonics to match. Its shares flew from 165p when floating in November 2014 to peak at 3,863p in September 2016.
That’s a rise of a mind-boggling 2,241%, which might have turned a £10,000 funding right into a life-changing £234,100. Sadly although, many latecomers may have discovered themselves nursing an almighty hangover.
Is the share value in a candy spot?
Immediately, Fevertree shares commerce at round 795p, a drop of 79.4% peak to trough. And the shares proceed to say no, down 27.11% over 12 months.
I resisted the temptation to leap on the share value bandwagon. I’m at all times cautious when a inventory flies so excessive, so quick, as traders can discover themselves chasing good points which have already been made.
I haven’t given Fevertree a lot thought for ages however lately noticed a dealer suggesting it was good worth and determined it was time to research. I like shopping for shares which have fallen out of favour and are ripe for a rebound. So is that this it?
Fevertree’s full-year 2024 outcomes, printed on 12 September, present income progress of two% 12 months on 12 months at fixed foreign money. That’s nothing to get enthusiastic about though because the board identified, that was regardless of the “subdued consumer backdrop and poor weather in the second quarter across the UK and Europe”.
The group posted a stronger July and August, the 2 months following these outcomes, with progress of 13%. Fevertree can also be increasing properly within the US, extending its market share and primary place in Tonic Water and Ginger Beer.
In one other optimistic, operational enhancements boosted gross margins by 520 foundation factors to 35.9%. The board additionally highlighted Fevertree’s robust steadiness sheet, which permits it to take a position for progress.
Premium product, dear valuation
These outcomes aren’t mind-blowing, however they aren’t unhealthy both. Fevertree can also be diversifying away from gin mixers into rum, vodka, cocktails, margarita and Bloody Marys. This appears sensible as gin mania will inevitably ebb.
Fevertree has held on to its market place and I’d anticipate revenues and income to glitter when rates of interest fall and the financial system revives. The issue is that we don’t know when that joyful day will arrive.
The board is optimistic, and anticipates being ready to return surplus money to shareholders throughout 2025. Whereas dividend per share progress has been sluggish recently, not less than it has grown, as this chart exhibits. The forecast yield is 2.1%.
Chart by TradingView
Revenues have steadily edged upwards, too, as my desk exhibits.
2019 | 2020 | 2021 | 2022 | 2023 |
£260.5m | £251.1m | £311.1m | £344.3m | £364.4m |
I assumed that following the crash, Fevertree could be low-cost. But its shares nonetheless commerce at a whopping 60 occasions trailing earnings. That appears costly to me. Whereas I believe the shares will come good, they might have additional to fall, first. I’ll stick the inventory on my watch listing, however not on my purchase listing.